Differences in the Cellular Immune Response during and after Treatment of Sudanese Patients with Post-kala-azar Dermal Leishmaniasis, and Possible Implications for Outcome

Differences in the Cellular Immune Response during and after Treatment of Sudanese Patients with Post-kala-azar Dermal Leishmaniasis, and Possible Implications for Outcome

Abstract Background The host cellular immune response associated with two treatments for post-kala-azar dermal leishmaniasis (PKDL) - paromomycin plus miltefosine (Arm 1), and liposomal amphotericin B plus miltefosine (Arm 2) - was examined in Sudanese patients before treatment (D0), at the end of t...

Full description

Bibliographic Details
Main Authors: Ana Torres, Brima Musa Younis, Mohammed Alamin, Samuel Tesema, Lorena Bernardo, Jose Carlos Solana, Javier Moreno, Alaa-aldeen Mustafa, Fabiana Alves, Ahmed Mudawi Musa, Eugenia Carrillo
Format: Article
Language:English
Published: Springer 2024-07-01
Series:Journal of Epidemiology and Global Health
Subjects:
PKDL
Leishmaniasis
Whole blood assay
Cytokines
Outcome
Treatment
Online Access:https://doi.org/10.1007/s44197-024-00270-0

Internet

https://doi.org/10.1007/s44197-024-00270-0

Similar Items